Desmoid tumor laboratory tests: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
| Line 35: | Line 35: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+Characteristic features of desmoid tumors on immunohistochemistry and relevant antibodies | |+Characteristic features of desmoid tumors on immunohistochemistry and relevant antibodies | ||
!Other diagnostic tests | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Other diagnostic tests | ||
!Associated characteristics features | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated characteristics features | ||
|- | |- | ||
|'''Immunohistochemistry''' | |style="background:#DCDCDC;" align="center" + |'''Immunohistochemistry''' | ||
(aids [[histologic]] [[diagnosis]])<ref name="pmid17711447">{{cite journal| author=Carlson JW, Fletcher CD| title=Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. | journal=Histopathology | year= 2007 | volume= 51 | issue= 4 | pages= 509-14 | pmid=17711447 | doi=10.1111/j.1365-2559.2007.02794.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17711447 }} </ref> | (aids [[histologic]] [[diagnosis]])<ref name="pmid17711447">{{cite journal| author=Carlson JW, Fletcher CD| title=Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. | journal=Histopathology | year= 2007 | volume= 51 | issue= 4 | pages= 509-14 | pmid=17711447 | doi=10.1111/j.1365-2559.2007.02794.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17711447 }} </ref> | ||
|[[Spindle cells]] on [[immunohistochemical stains]] show the following [[Features (pattern recognition)|features]]: | |[[Spindle cells]] on [[immunohistochemical stains]] show the following [[Features (pattern recognition)|features]]: | ||
| Line 51: | Line 51: | ||
**[[S-100]] | **[[S-100]] | ||
|- | |- | ||
|'''Antibodies''' | |style="background:#DCDCDC;" align="center" + |'''Antibodies''' | ||
|In order to distinguish [[Desmoid tumor|desmoid tumors]] from other [[tumors]], following [[antibodies]] are often examined: | |In order to distinguish [[Desmoid tumor|desmoid tumors]] from other [[tumors]], following [[antibodies]] are often examined: | ||
*[[Smooth muscle]] [[actin]] | *[[Smooth muscle]] [[actin]] | ||
| Line 57: | Line 57: | ||
*KIT | *KIT | ||
|- | |- | ||
|'''APC germline mutational analysis''' | |style="background:#DCDCDC;" align="center" + |'''APC germline mutational analysis''' | ||
| | | | ||
* Sporadic [[desmoid tumor]] [[patients]] with no [[clinical]] or [[familial]] [[signs]] of [[Familial adenomatous polyposis|familial adenomatous polyposis (FAP)]] but having a [[family history]] of [[colorectal carcinoma]] in at least one [[family]] member | * Sporadic [[desmoid tumor]] [[patients]] with no [[clinical]] or [[familial]] [[signs]] of [[Familial adenomatous polyposis|familial adenomatous polyposis (FAP)]] but having a [[family history]] of [[colorectal carcinoma]] in at least one [[family]] member | ||
Latest revision as of 03:35, 25 March 2019
|
Desmoid tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
Immunohistochemical staining of spindle cells of desmoid tumors are positive for nuclear beta-catenin, vimentin, alpha smooth muscle actin, muscle actin and negative for desmin, cytokeratins, and S-100. Antibodies like smooth muscle actin, desmin and KIT may be helpful in distinguishing desmoid tumors from other tumors. In addition, APC germline mutations may be performed in patients with sporadic desmoid tumors with no clinical or famililal signs of FAP but having a family history of colorectal carcinoma in at least one family member.
Laboratory tests
- Molecular testing can be performed in general by performing a variety of following methods:
- In situ hybridization technique, such as fluorescence in situ hybridization (FISH)
- Immunohistochemistry (IHC)
- Next-generation sequencing (NGS)
- Polymerase chain reaction (PCR)
- Comparative genomic hybridization (CGH)
- Karyotyping including spectral karyotyping
- mRNA analysis
- Tissue microarrays (TMAs)
- Southern blot test
- Northern blot test
- Western blot test
- Eastern blot test
Clinical indications for performing molecular testing
- Molecular testing for desmoid tumor is done in order to:
- Assist (and in some cases, confirm) the initial diagnosis of desmoid tumor
- Distinguish other tumors/conditions that have similar histological features, when examined by a pathologist under the microscope
- Help in determining treatment options
- Confirm recurrence of the tumor: Tumor recurrence can either be at the original tumor site, or at a distant location (away from the initial site)
Significance of Molecular Testing
- Molecular testing in desmoid tumor has following significance:
- Presence of a positive test result helps aid, and in some cases, confirm the diagnosis of desmoid tumor
- Result can help to exclude other tumors having similar histological features
- It can help in determining the prognosis of the patient
- Test results may help in making treatment decisions in some cases
| Other diagnostic tests | Associated characteristics features |
|---|---|
| Immunohistochemistry
(aids histologic diagnosis)[1] |
Spindle cells on immunohistochemical stains show the following features:
|
| Antibodies | In order to distinguish desmoid tumors from other tumors, following antibodies are often examined:
|
| APC germline mutational analysis |
|
Reference
- ↑ Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.